Melissa Dobson
BSc (Hons)
Head of Operations
Head of Operations, Oxford Respiratory Trials Unit
I have worked at the Oxford Respiratory Trials Unit since 2009. My current role involves managing a team of research professionals to deliver the trials being run through the unit. I ensure that appropriate funding, systems and resources are in place to ensure trials are delivered on time and within budget, and meet the appropriate clinical trial and research governance requirements.
Prior to joining ORTU I worked in the Pharmaceutical/Biotech Industry for over 10 years. I have worked across a range of therapeutic areas and phases of trials in various roles including trial management and monitoring, data management, feasibility and strategy development.
Recent publications
Optimising antibiotic ‘review and revise’ in acute/general medical inpatients: the Antibiotic Review Kit in Hospitals (ARK-Hospital) research programme including a stepped-wedge cluster-randomised trial
Journal article
Llewelyn MJ. et al, (2026), Programme Grants for Applied Research, 1 - 82
Nirmatrelvir–ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022–23: virological and immunological results of an open-label randomised trial (PANORAMIC)
Journal article
Lowe DM. et al, (2026), The Lancet Microbe, 7, 101360 - 101360
Vibrotactile positional therapy for the treatment of positional obstructive sleep apnoea: a multicentre, randomised controlled trial
Journal article
Kelly JL. et al, (2026), Thorax, 81, 370 - 379
Intravenous iron for the treatment of iron deficiency in adults with cystic fibrosis: a prospective observational cohort study
Journal article
Talbot NP. et al, (2025), European Respiratory Journal, 66, 2500838 - 2500838
A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration
Journal article
Nguyen BT. et al, (2025), The Journal of Infectious Diseases, 231, e1080 - e1090
